Search

Search results

218 results found

Individualizing Dual Antiplatelet Therapy (DAPT) Duration Based on Bleeding Risk, Ischemic Risk, or Both: An Analysis From the DAPT Study.

Mihatov, Nino, Eric A Secemsky, Dean J Kereiakes, Gabriel Steg, Donald E Cutlip, Ajay J Kirtane, Roxana Mehran, et al. 2022. “Individualizing Dual Antiplatelet Therapy (DAPT) Duration Based on Bleeding Risk, Ischemic Risk, or Both: An Analysis From the DAPT Study.”. Cardiovascular Revascularization Medicine : Including Molecular Interventions 41: 105-12.

BIDMC Nationally Recognized for High-Quality Cardiovascular Care

The American Heart Association Presents the Get With the Guidelines for Proven Dedication To Best Practices and Life-Saving Care BOSTON – Beth Israel Deaconess Medical Center has received six American Heart Association Get With The Guidelines achievement awards for demonstrating commitment to...

Our Team

Replace this text with a sentence or two about your team.

News + Updates

Powerful websites to share your science story: from team and research to publications and impact.